Eli Lilly

Sanofi Challenges Lilly’s Challenge of Lantus Patents

Germany's Merck Sees Long-Term Growth in Cancer Drug Erbitux

Teva to Drop Depression Treatment after Trial Fails

Eli Lilly 'Deeply Concerned' By Bribery Allegations in China

Eli Lilly Defends Blockbuster Alimta With Unusual Ammo

China to Launch Fresh Pharmaceutical Bribery Probe

China Investigates France's Sanofi for Alleged Bribery

Drug Makers Fear Short-Term Turmoil As China Probes Widen

China Widens Drug Industry Probe, Visits Belgium’s UCB

China Blocks GSK Finance Head From Leaving Country

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

After Tech Success, Israel Seeks Life Sciences Growth

Eli Lilly CEO Recovering After Repair to Aorta

Eli Lilly Broadens Diabetes Offer

U.S. Launch of Novo's New Insulin Faces Long Delay

Strong Pet Product Sales Help Zoetis Top Estimates

Drugmaker Eli Lilly to Cut 1,000 U.S. Sales Jobs

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Antibiotics Crisis Prompts Rethink on Risks, Rewards

Obama Medicare Rebate Plan Could Hurt Drug Companies

Amgen Biosimilar Push Takes Aim at Blockbusters

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

Eli Lilly Q4 Profits Hurt by Generic Competition

Drug Industry Bets on New Blockbusters in 2013

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

Drug Industry Treading Water on R&D Productivity

White House Said to Be Frustrating US Drug Companies in Asia Trade Talks

Topics • Technology

Thriving Generics

Changing Times

AstraZeneca Buys Equal Say over Amylin Drugs

Eli Lilly Raises 2012 Net Profit Forecast

Generics Seen Cutting into Drug Sales Growth through 2016

Survey Shows Dim Faith in Lilly, Pfizer Alzheimer's Drugs

Lilly Resumes Share Buybacks After Long Absence

29 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Eli Lilly and Company

Oracle Germany

Camelot Management Consultants AG

SchüllerConsulting

IEDC Europe Indiana

GlaxoSmithKline (GSK) plc

DCAT - Drug, Chemical & Associated Technologies Association

CONTINUUS Pharmaceuticals, Inc.

Fitch Ratings

Lilly Deutschland GmbH

Microinnova Engineering GmbH

Isomorphic Labs

Frost & Sullivan

Sanofi S.A.